Dr. Reddy’s Laboratories Releases Q2 FY27 Earnings Call Transcript
Dr Reddys Laboratories Ltd · Press Release · 30 Oct 2026, 4:23 am
Dr. Reddy’s Laboratories Releases Q2 FY27 Earnings Call Transcript Dr. Reddy’s Laboratories has submitted the transcript of its earnings call held on 23rd Oct'26 for the quarter and half-year ended 30th Sep'26 (Q2 FY27). The disclosure was made pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and the complete transcript is accessible on the company's website.
Original exchange filing (PDF)
More announcements from Dr Reddys Laboratories Ltd
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 · 14 Nov 2026
- Intimation of Analyst meet · 11 Nov 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 · 05 Nov 2026
- Allotment of Employee Stock options · 04 Nov 2026
- Clarification - Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 · 04 Nov 2026
- The Exchange has sought Clarification from Dr Reddys Laboratories Ltd with reference to the media report appearing on https://www.firstpost.com dated November 03, 2026 (Link : https://www.firstpost.com/business/indias-dr-reddys-gets-us-nod-for-40-generic-hiv-prevention-shot-for-120-poorer-countries-14057224.html) .... · 03 Nov 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 · 28 Oct 2026
- Audio Recording of the Earnings call conducted on October 23, 2026 · 24 Oct 2026
